Michael K. Jackson is Interim CFO at PONIARD PHARMACEUTICALS, INC. (PARD). They have made 6 open-market trades across 1 company since 2009, most recently 2012-03-27.
CIK 0001287535
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PARD | 5,925 | — |
Shares reported on the most recent Form 4, priced at the 2012-03-27 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PARD | SELL | 2012-03-27 | 2012-03-27 | $0.83 | $213 | N/A | N/A | N/A |
| PARD | SELL | 2012-02-16 | 2012-02-17 | $0.87 | $2K | N/A | N/A | N/A |
| PARD | SELL | 2011-04-13 | 2011-04-14 | $0.37 | $3K | N/A | N/A | N/A |
| PARD | SELL | 2011-01-05 | 2011-01-07 | $0.52 | $23K | N/A | N/A | N/A |
| PARD | SELL | 2010-02-08 | 2010-02-09 | $1.62 | $6K | N/A | N/A | N/A |
| PARD | SELL | 2009-11-25 | 2009-12-10 | $2.23 | $2K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.